Canada markets close in 3 hours 49 minutes

UTHR Aug 2021 200.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
15.800.00 (0.00%)
As of 1:39PM EDT. Market open.
Full screen
Loading interactive chart...
  • United Therapeutics (UTHR) Q1 Earnings Miss, Sales Beat
    Zacks

    United Therapeutics (UTHR) Q1 Earnings Miss, Sales Beat

    United Therapeutics (UTHR) reports mixed first-quarter 2021 results. Higher sales of Orenitram, Unituxin and Tyvaso offset lower sales of Remodulin and Adcirca.

  • United Therapeutics Corp (UTHR) Q1 2021 Earnings Call Transcript
    Motley Fool

    United Therapeutics Corp (UTHR) Q1 2021 Earnings Call Transcript

    It's my pleasure to welcome you to the United Therapeutics Corporation First Quarter 2021 Earnings Call. Accompanying me on today's call are Dr. Martine Rothblatt, our Chairperson and Chief Executive Officer; Mr. Michael Benkowitz, our President and Chief Operating Officer; Mr. James Edgemond, our Chief Financial Officer and Treasurer; and Dr. Leigh Peterson, our Senior Vice President of Product Development.

  • United Therapeutics (UTHR) Lags Q1 Earnings Estimates
    Zacks

    United Therapeutics (UTHR) Lags Q1 Earnings Estimates

    United Therapeutics (UTHR) delivered earnings and revenue surprises of -76.54% and 3.37%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?